Washington University in St. Louis | OVCR
Home > Research News Print Page
HRPO: New IRB Fees

Posted Date: 1/15/2015 3:37 PM

Content Categories: Other

Subject: HRPO: New IRB Fees


We are announcing a revised fee schedule for research studies submitted to the Institutional Review Board (IRB) that are supported by for-profit entities. The new fee schedule is listed below (Table 1) and becomes effective for all reviews as of July 1, 2015. These fees reflect current peer institution and industry standards. We have also included our current fee structure (Table 2) for comparison purposes.

                                                   Table 1 
                                             REVISED IRB FEES
                                        EFFECTIVE: July 1, 2015

​Type of Study
​Initial Review
(includes adding a
sponsor with a
modification)
​Continuing
Review
​Any Time
​Full Board Review ​$2,500 ​$1,500
​Expedited Review ​$2,500 ​$1,500
​WU IRB for additional
Site/Investigator*
​$1,250 ​$1,250
​Protocol and/or Consent
change required by for-
profit entity
​$500
​Informed Consent Change
from Template Injury
Language
​$500
 * Outside WU, BJH, SLCH


                                             Table 2
                        Current IRB FEES (thru June 30, 2015)

​Type of Study ​Initial Review ​Continuing Review
​Full Board ​$2,500 ​$1,500
​Expedited/Exempt ​$1,250 ​$1,250
​Informed Consent Change from
Template Injury Language
​$500 (at any time)
 


The Human Research Protection Office (HRPO) currently charges for IRB review of any research studies that are supported by for-profit companies. This includes:

 
      • For-profit supported studies
      • Industry supported studies
      • PI initiated studies
      • Either clinical trials or non-clinical trials


There are no fees assessed for review of research studies funded solely by federal or state agencies, not-for-profit foundations, or for internally funded research. 


Payment of IRB reviewing fees is required for all research studies that receive financial support from a for-profit sponsor, regardless of the designation of the support, for example: If you are only receiving drug or device, IRB fees will not be charged, however, if you are receiving any type of funding, for any other support, IRB reviewing fees will be charged.

IRB fees are non-refundable. The fees are an assessment for the administrative costs associated with IRB review. Because HPRO commits its full resources to each review, the fees are due in full, even if the study is not approved, is withdrawn after submission, participants are never enrolled, a research contract is never executed, or the study is terminated before the study objectives are achieved. HRPO requires payment of the fees prior to releasing the study for accrual. 


Questions regarding the fee policy may be directed to me or to Martha Jones, Executive Director of HRPO.


Richard J. Stanton
Associate Vice Chancellor Administration and Finance

 
Attachments:

This information was authored by Carla Pinkston  

This message was sent to all Research News subscribers
This message was sent to Research News subscribers in the following Job Function(s):   Faculty - Human Studies Research; Research Administrative Staff - Human Studies Research; Research Staff - Human Studies Research
This message was sent to the following Research News subscriber(s):  
This message was sent to the following Office/Department(s):